Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
"Dear Doctor - Participate in this fun and exciting Quiz on Neonatal jaundice. Neonatal jaundice is a yellowing of the skin and eyes in newborn infants. It occurs when there is an excess of bilirubin, a yellow pigment that is produced when red blood cells break down. Bilirubin is normally removed from the body by the liver, but in newborns, the liver is not yet fully developed and cannot remove bilirubin efficiently. As a result, bilirubin can build up in the blood and cause jaundice. Jaundice itself is not harmful and will usually go away on its own within 2 to 3 weeks. However, if left untreated, it can lead to serious complications such as brain damage or kernicterus. Kernicterus is a type of brain damage that can occur when bilirubin levels are very high and enter the brain. For this reason, it is important to monitor neonatal jaundice closely and treat it promptly if necessary. Participate Now."
1.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
2.
Breast cancer patients' arms swell less after an effective lymph node transfer.
3.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
4.
Ineffective medication can remove the "worst fear" of schizophrenia.
5.
Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics
1.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
2.
A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures
3.
Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma
4.
Case Study: Genomic Medicine in Precision Oncology
5.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
Recommended News For You
1.
Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.
2.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
3.
Obesity-related cancer rising among both younger and older adults worldwide, study finds
4.
Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer
5.
CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas
Conferences That Might Interest You
Recommended Articles For You
1.
Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
4.
The Importance of Balanced Potassium Levels in Maintaining Good Health
5.
The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy
Boost Your Knowledge With These Quizzes
1.
Quiz on the Approach to Complex Shoulder Instability: Are You Prepared to Differentiate Between Types of Instability, Conduct Thorough Assessments, Interpret Diagnostic Imaging Accurately, and Implement Comprehensive Management Strategies That Include Sur
2.
Quiz on Update on the Use of Corticosteroids in Rheumatic Diseases: Are You Ready to Tackle the Steroid Puzzle in Modern Treatment?
3.
Quiz On Acute Liver Failure
4.
Quiz on Checkpoint Inhibitors: The Future of Immunotherapy in Cancer
5.
Quiz on Cancer Stem Cells and Tumor Recurrence
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge